Price

rebased to 0%

PALI, solidAMGN, dashed

PALIPalisade Bio, Inc.

1.14−2.14%· post 1.14

Mkt cap$196.9MRevenue$500,000Q2 FY26Revenue—

AMGNAmgen Inc

460.55+0.06%· post 460.42

ClosedNov 6 '26

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

vs

Compare

ClosedNov 6 '26

PALIPalisade Bio, Inc.

vs

AMGNAmgen Inc

1.14−2.14%post 1.14

Price

460.55+0.06%post 460.42

$196.9M

Mkt cap

$249.0B

Q2 FY26$500,000

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

PALI compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name